Post by BioDuro

📢Before 𝗕𝗜𝗢 𝟮𝟬𝟮𝟲, we wanted to share what’s new from BioDuro. Our CCO, Susan Reasoner, recently joined Fierce Biotech’s BIO Preview virtual event, sharing where BioDuro is headed across drug discovery, CMC, and manufacturing. She also talked about BioDuro's continued investment in peptide capabilities, from DEL-enabled discovery and AI-assisted design to SPPS and LPPS synthesis, oral formulation, and integrated DMPK including MetID. We look forward to continuing these conversations at 𝗕𝗼𝗼𝘁𝗵 𝟰𝟴𝟱𝟳. #BIO2026 #DrugDiscovery #Peptide #CMC

Video Content